BB Biotech AGXSWX:BION +2.14%33 Pretax Margin % is 125.34% as of Mar. 2026, which is 25% above its 10-year median of 99.96. GuruFocus rates XSWX:BION with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 947 Biotechnology companies, BB Biotech AG ranks better than 97.99% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. BB Biotech AG's Pre-Tax Income for the
three
months ended in Mar. 2026 was CHF-21.4 Mil. BB Biotech AG's Revenue for the
three
months ended in Mar. 2026 was CHF-17.0 Mil. Therefore, BB Biotech AG's pretax margin for the quarter that ended in Mar. 2026 was 125.34%.
The historical rank and industry rank for BB Biotech AG's Pretax Margin % or its related term are showing as below:
XSWX:BION'
s Pretax Margin % Range Over the Past 10 Years
Min: 92.27 Med: 99.96 Max: 103.49
Current: 97.47
XSWX:BION's Pretax Margin % is ranked better than 97.99% of 947
companies
in the Biotechnology industry
Industry Median: -90.63
vs XSWX:BION: 97.47
BB Biotech AG (XSWX:BION) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
BB Biotech AG Pretax Margin % Related Terms
BB Biotech AG Pretax Margin % Historical Data
* Premium members only.
The historical data trend for BB Biotech AG's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:BION vs VRTX, REGN, ALNY: Pretax Margin % Comparison
For the Biotechnology subindustry, BB Biotech AG's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BB Biotech AG Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BB Biotech AG's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where BB Biotech AG's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BB Biotech AG (XSWX:BION) has a Pretax Margin % of 125.34% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on BB Biotech AG and its competitors. This is 25% above median its historical median of 99.96. Over the past decade, BB Biotech AG's Pretax Margin % has ranged from 92.27 to 103.49. According to the industry distribution chart, BB Biotech AG ranks #19 out of 947 companies in the Biotechnology industry, placing it in the top 2%.
Is BB Biotech AG's Pretax Margin % too high?
BB Biotech AG's current Pretax Margin % of 125.34% is 25% above median its 10-year median of 99.96. Over the past 10 years, this metric has ranged from a low of 92.27 to a high of 103.49. Based on the distribution chart, BB Biotech AG ranks #19 out of 947 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, BB Biotech AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BB Biotech AG ranks #19 out of 947 companies for Pretax Margin %. This places BB Biotech AG in the top 2% of its industry — outperforming the majority of peers. Historically, BB Biotech AG's own Pretax Margin % has ranged from 92.27 to 103.49 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on BB Biotech AG and its competitors. BB Biotech AG's current Pretax Margin % is 125.34%, which is 25% above median its own 10-year median of 99.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current Pretax Margin % of 125.34%. The current Pretax Margin % is 125.34%, which is 25% above median its 10-year median of 99.96. BB Biotech AG's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current Pretax Margin % is 125.34% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
33GF Score
Get the complete analysis for XSWX:BION
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:BION has been successfully added to your 
